275 related articles for article (PubMed ID: 20561438)
1. [Immune changes in type 1 diabetes animal model after syngeneic bone marrow transplantation].
Lü CL; Ouyang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):726-30. PubMed ID: 20561438
[TBL] [Abstract][Full Text] [Related]
2. The variance of peripheral blood lymphocyte subsets of streptozotocin-induced diabetic mice after bone marrow transplantation.
Wang J; Lv C; Xie T; Ouyang J
Int J Clin Exp Med; 2015; 8(3):4115-21. PubMed ID: 26064318
[TBL] [Abstract][Full Text] [Related]
3. Time point is important for effects of syngeneic bone marrow transplantation for type 1 diabetes in mice.
Wen Y; Ouyang J; Li W; Chen J; Liu Y; Meng L; Zhang H; Zhou X
Transplant Proc; 2009 Jun; 41(5):1801-7. PubMed ID: 19545732
[TBL] [Abstract][Full Text] [Related]
4. Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation.
Wen Y; Ouyang J; Yang R; Chen J; Liu Y; Zhou X; Burt RK
Biochem Biophys Res Commun; 2008 Sep; 374(2):282-7. PubMed ID: 18625200
[TBL] [Abstract][Full Text] [Related]
5. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
6. [Reconstitution of peripheral blood lymphocytes in patients treated with bone marrow transplantation: comparison between allogeneic and autologous transplantation].
Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Oteho E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
Med Clin (Barc); 1999 Jun; 113(1):1-5. PubMed ID: 10422068
[TBL] [Abstract][Full Text] [Related]
7. [Immunologic reconstitution of peripheral blood lymphocytes in patients treated by bone marrow transplantation].
Parra C; Roldán E; Rodríguez C; Pérez de Oteyza J; Otheo E; López J; Maldonado MS; García Laraña J; Muñoz A; Odriozola J; Brieva JA
Med Clin (Barc); 1996 Feb; 106(5):169-73. PubMed ID: 8684015
[TBL] [Abstract][Full Text] [Related]
8. Changes of lymphocyte subsets in leukemia patients who received allogenic bone marrow transplantation.
Komatsuda M
Acta Med Okayama; 1991 Aug; 45(4):257-65. PubMed ID: 1683740
[TBL] [Abstract][Full Text] [Related]
9. Prolonged survival in mice with advanced tumors treated with syngeneic or allogeneic intra-bone marrow-bone marrow transplantation plus fetal thymus transplantation.
Hosaka N; Cui W; Zhang Y; Takaki T; Inaba M; Ikehara S
Cancer Immunol Immunother; 2010 Jul; 59(7):1121-30. PubMed ID: 20229083
[TBL] [Abstract][Full Text] [Related]
10. [Effects of natural killer cells on engraftment and reconstitution of hematopoiesis and immunity in mice undergoing allogeneic bone marrow transplantation].
Yang ZG; Xiong D; Zeng YY; Liang L; Li QH; Wu GC
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):627-32. PubMed ID: 18549643
[TBL] [Abstract][Full Text] [Related]
11. Syngeneic bone marrow transplantation in combination with PI3K inhibitor reversed hyperglycemia in later-stage streptozotocin-induced diabetes.
Zhang S; Dai Q; Zhang B; Liu S; Wang Y; Zhang Y; Chen D; Zong N; Wang H; Ding J; Gao Q; Wen Y
Ann Transl Med; 2021 Nov; 9(22):1642. PubMed ID: 34988151
[TBL] [Abstract][Full Text] [Related]
12. Preventive effects of syngeneic bone marrow transplantation on diabetic nephropathy in mice.
Ouyang J; Hu G; Wen Y; Zhang X
Transpl Immunol; 2010 Feb; 22(3-4):184-90. PubMed ID: 20045460
[TBL] [Abstract][Full Text] [Related]
13. Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and allogeneic bone marrow transplantation.
Roberts MM; To LB; Gillis D; Mundy J; Rawling C; Ng K; Juttner CA
Bone Marrow Transplant; 1993 Nov; 12(5):469-75. PubMed ID: 7905331
[TBL] [Abstract][Full Text] [Related]
14. [Changes of lymphocyte subsets in peripheral blood of patients with hepatitis C].
Wan H; Li Y; Yang N; Yuan W; Xie N; Wang D; Guo T; Mao Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Oct; 30(10):1058-61. PubMed ID: 25270208
[TBL] [Abstract][Full Text] [Related]
15. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
[TBL] [Abstract][Full Text] [Related]
16. Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation.
Meng L; Ouyang J; Zhang H; Wen Y; Chen J; Zhou J
Restor Neurol Neurosci; 2011; 29(3):177-85. PubMed ID: 21586824
[TBL] [Abstract][Full Text] [Related]
17. Sequential analysis of the thymocyte differentiation in fully allogeneic bone marrow chimera in mice. II. Further characterization of the CD4+ or CD8+ single positive thymocytes.
Arase H; Fukushi N; Hatakeyama S; Ogasawara K; Iwabuchi K; Iwabuchi C; Negishi I; Good RA; Onoé K
Immunobiology; 1990 Feb; 180(2-3):167-83. PubMed ID: 2140562
[TBL] [Abstract][Full Text] [Related]
18. Effects of ex vivo activated immune cells on syngeneic and semi-allogeneic bone marrow transplantation in mice.
Yang G; Tan J; Wei G; Deng Y; Chen H; Yang D
Transpl Immunol; 2006 Nov; 16(3-4):166-71. PubMed ID: 17138049
[TBL] [Abstract][Full Text] [Related]
19. The expression patterns of CD44 and CD45RB on peripheral blood T lymphocytes in the rejection of allogeneic murine skin transplantation.
Yang J; Ahn C; Jung HK; Kim EK; Kim JY; Kim YS; Han JS; Kim S; Lee JS
Transpl Immunol; 2003; 11(2):197-206. PubMed ID: 12799204
[TBL] [Abstract][Full Text] [Related]
20. [Comparative analysis of early reconstitution of T-lymphocyte subsets and T-cell receptor excision cycles in patients after myeloablative unrelated cord blood and sibling donor transplantation].
Nie H; Wang J; Lu YJ; Zheng CC; Tang BL; Yao W; Zhu XY; Qiang P; Zhang L; Liu HL; Sun ZM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr; 22(2):440-6. PubMed ID: 24763020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
